In addition, PER3 is downregulated in colorectal cancer stem-like cells (CSCs) and in drug-resistant colon cancer cells in vitro [49], which clearly indicates that deregulation of PER3 expression might be an underlying event in the development of chemoresistance in colon cancer. Here, PER3 is linked to colorectal cancer.